TriangleNCT02717507 · OUTCOME
Average Cardiac Troponin I
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEAN
- Unit
- ng/mL
- Interval / dispersion
- Standard Error
- Time frame
- Baseline before treatment, 6 months, 12 months, 18 months, 24 months after treatment initiation
What was measured
Troponin I is a biomarker for myocardial cell injury (in ng/ml). The mean is reported by arm at each timepoint with corresponding standard errors.
Analysis population: We excluded 31 participants who did not have a second time point assessment of echocardiography, resulting in 151 analyzable participants.
Groups in this outcome
Arm I (Carvedilol)
Patients received Carvedilol PO delivered at 6.25 mg twice daily (for a total dose of 12.5 mg per day) for 24 months.
Arm II (Placebo)
Patients received Placebo PO delivered at 6.25 mg twice daily (for a total dose of 12.5 mg per day) for 24 months.
| Group | Source count |
|---|---|
| Arm I (Carvedilol) | 75 |
| Arm II (Placebo) | 76 |
Reported measurements
BL
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm I (Carvedilol) | 0.00446 | 0.0024 | Not reported | Not reported | Not reported |
| Arm II (Placebo) | 0.0011 | 0.0008 | Not reported | Not reported | Not reported |
6m
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm I (Carvedilol) | 0.00265 | 0.001 | Not reported | Not reported | Not reported |
| Arm II (Placebo) | 0.00174 | 0.0009 | Not reported | Not reported | Not reported |
12m
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm I (Carvedilol) | 0.00467 | 0.0014 | Not reported | Not reported | Not reported |
| Arm II (Placebo) | 0.00742 | 0.0034 | Not reported | Not reported | Not reported |
18m
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm I (Carvedilol) | 0.00737 | 0.0017 | Not reported | Not reported | Not reported |
| Arm II (Placebo) | 0.00684 | 0.0017 | Not reported | Not reported | Not reported |
24m
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm I (Carvedilol) | 0.01111 | 0.002 | Not reported | Not reported | Not reported |
| Arm II (Placebo) | 0.01132 | 0.002 | Not reported | Not reported | Not reported |
Source statistical analyses
- ci Lower Limit
- -0.004
- ci Num Sides
- TWO_SIDED
- ci Pct Value
- 95
- ci Upper Limit
- 0.002
- dispersion Type
- STANDARD_ERROR_OF_MEAN
- dispersion Value
- 0.001
- group Ids
- OG000
- OG001
- non Inferiority Type
- OTHER
- p Value
- 0.51
- param Type
- Slope
- param Value
- -0.001
- statistical Comment
- The treatment effect was determined by testing the significance of the group by time interaction in GEE using a one degree-of-freedom (df) test.
- statistical Method
- Generalized Estimating Equation (GEE)
Complete source fields
- analyses
- ci Lower Limit
- -0.004
- ci Num Sides
- TWO_SIDED
- ci Pct Value
- 95
- ci Upper Limit
- 0.002
- dispersion Type
- STANDARD_ERROR_OF_MEAN
- dispersion Value
- 0.001
- group Ids
- OG000
- OG001
- non Inferiority Type
- OTHER
- p Value
- 0.51
- param Type
- Slope
- param Value
- -0.001
- statistical Comment
- The treatment effect was determined by testing the significance of the group by time interaction in GEE using a one degree-of-freedom (df) test.
- statistical Method
- Generalized Estimating Equation (GEE)
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 0.0024
- value
- 0.00446
- group Id
- OG001
- spread
- 0.0008
- value
- 0.0011
- title
- BL
- categories
- measurements
- group Id
- OG000
- spread
- 0.001
- value
- 0.00265
- group Id
- OG001
- spread
- 0.0009
- value
- 0.00174
- title
- 6m
- categories
- measurements
- group Id
- OG000
- spread
- 0.0014
- value
- 0.00467
- group Id
- OG001
- spread
- 0.0034
- value
- 0.00742
- title
- 12m
- categories
- measurements
- group Id
- OG000
- spread
- 0.0017
- value
- 0.00737
- group Id
- OG001
- spread
- 0.0017
- value
- 0.00684
- title
- 18m
- categories
- measurements
- group Id
- OG000
- spread
- 0.002
- value
- 0.01111
- group Id
- OG001
- spread
- 0.002
- value
- 0.01132
- title
- 24m
- denoms
- counts
- group Id
- OG000
- value
- 75
- group Id
- OG001
- value
- 76
- units
- Participants
- description
- Troponin I is a biomarker for myocardial cell injury (in ng/ml). The mean is reported by arm at each timepoint with corresponding standard errors.
- dispersion Type
- Standard Error
- groups
- description
- Patients received Carvedilol PO delivered at 6.25 mg twice daily (for a total dose of 12.5 mg per day) for 24 months.
- id
- OG000
- title
- Arm I (Carvedilol)
- description
- Patients received Placebo PO delivered at 6.25 mg twice daily (for a total dose of 12.5 mg per day) for 24 months.
- id
- OG001
- title
- Arm II (Placebo)
- param Type
- MEAN
- population Description
- We excluded 31 participants who did not have a second time point assessment of echocardiography, resulting in 151 analyzable participants.
- reporting Status
- POSTED
- time Frame
- Baseline before treatment, 6 months, 12 months, 18 months, 24 months after treatment initiation
- title
- Average Cardiac Troponin I
- type
- SECONDARY
- unit Of Measure
- ng/mL
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice